(Q34574840)

3 August 2017

1 reference

title

The role of Epstein-Barr virus in cancer (English)

1 reference

3 August 2017

0 references

Paul J Farrell

2

0 references

author name string

Samuel B Pattle

series ordinal

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

Expert Opinion on Biological Therapy

3 August 2017

published in

1 reference

3 August 2017

volume

6

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

1193-1205

1 reference

Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

EBV the prototypical human tumor virus--just how bad is it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Adult Burkitt's lymphoma in patients with and without human immunodeficiency virus infection in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

A children's cancer dependent on climatic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Circulating Epstein-Barr virus-carrying B cells in acute malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Cell kinetics of African cases of Burkitt lymphoma. A preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus provides a survival factor to Burkitt's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

The protein kinase PKR: a molecular clock that sequentially activates survival and death programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

The role of the Bcl-2 protein family in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus-associated Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus in AIDS-related primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Improving T cell therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Mitogenic activity of Epstein-Barr virus-encoded BARF1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Caspase 9 activation by the dsRNA-dependent protein kinase, PKR: molecular mechanism and relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1193

10.1517/14712598.6.11.1193

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference